タイトル無し
スポンサーリンク
概要
- 論文の詳細を見る
A multi-center double-blind study in comparison with aspirin was conducted to evaluate the effectiveness, safety and usefulness of Suprofen (TO-177), a new non-steroidal analgesic/anti inflammatory agent, in tooth extraction of mandibular impacted wisdom tooth.<BR>Patients were treated with Suprofen (SP) 100mg three times a day or aspirin (AP) 500mg three times a day.<BR>The results were obtained as follows.<BR>1) Total treated cases were 272 (SP: 133 cases, AP: 139 cases) . 4 cases were excluded.<BR>2) According to the clinical efficacy, the ratio of"good or better"was 74.4% with SP group and 61.2% with AP group. There was a significant difference between two groups (<I>p</I><0.001) .<BR>3) Side effects were reported 3 cases (2.3%) SP group and 10 cases (5.1%) AP group.<BR>4) In the general utility rating, the ratio of"useful or better"was 72.7% with SP group and 56.7% with AP group. There was a significant difference between two groups (<I>p</I><0.001) .<BR>The results indicate that Suprofen is a safe and useful anti inflammatory analgesic agent.
- 日本歯科薬物療法学会の論文
日本歯科薬物療法学会 | 論文
- カンジダのバイオフィルム産生性に対する抗真菌薬の効果
- 当院における全身麻酔下手術中に使用された抗菌薬の15年間(1992-2006年)の推移
- 「顎骨骨髄炎に対する抗菌薬の効果判定基準」の解析結果
- 植物精油の口腔微生物に対する抗菌性およびバイオフィルム形成抑制効果の検討
- ニフェジピン歯肉増殖症患者の線維芽細胞に対する18α-グリチルレチン酸のアポトーシス誘導効果